I agree. I'm Looking forward to the DFU results and it will be interesting to see how stem cells compare with soft tissue compared to cartlidge regeration.
If we can get some positive results from the DFU and management can cut some sort of deal without giving away the company, maybe there will be some light at the end of the tunnel.
Ann: Phase 3 Osteoarthritis Clinical Trial Commences, page-394
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.015(5.45%) |
Mkt cap ! $52.09M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 29.0¢ | 27.5¢ | $36.15K | 125.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 21519 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 41478 | 4 |
View Market Depth
| Last trade - 15.45pm 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
28.5¢ |
Change
0.015 ( 2.15 %) |
||||
| Open | High | Low | Volume | ||
| 28.5¢ | 28.5¢ | 28.5¢ | 13201 | ||
| Last updated 15.26pm 27/05/2024 ? | |||||
| CYP (ASX) Chart |